Thematic

globenewswire.com

uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease

Read the original →

What this article backs

• Uniqure ✚ Fda Approval

• Uniqure enables Fda Approval.

In its own words

uniQure Announces Plan for BLA Submission for AMT-130 in Huntington's Disease